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Bringing the economic cost of 
informal caregiving into focus
Do specialised palliative care services improve outcomes 
for patients with advanced progressive illness at the end of 
life and their families at lower or acceptable cost compared 
with traditional health and social care services? Health 
economics research can help answer this question. 
Economic evaluations systematically compare the relative 
costs and benefits of competing options and thus provide 
information about how best to improve patient and family 
outcomes within funding constraints. Costs and outcomes 
are jointly considered to evaluate how best to achieve 
value for money from scarce resources. However, there is 
sparse evidence on the efficiency and equity of palliative 
and end-of-life care, in part due to the difficulties associ-
ated with conducting research in this context, particularly 
measuring costs and outcomes.1
Four papers in this issue of Palliative Medicine make 
important contributions to the study of costs in palliative 
care, and between them, highlight one of the key issues in 
measuring these costs: how to capture and value impacts on 
informal caregivers, often family members. In this context, 
an informal caregiver is someone who provides regular, 
ongoing assistance to a person with advanced progressive 
illness at the end of life without receiving payment for the 
care given.2 Informal caregivers, not healthcare systems, 
provide the majority of care for people at the end of life, yet 
health service evaluations often ignore both the outcomes 
and costs borne by this group. Family members and friends 
are integral to palliative care service provision. Without 
their support, patient preferences for home-based care at the 
end of life would often be unachievable.3 Broad social 
changes such as smaller, more geographically dispersed 
families, higher divorce rates and changing communities are 
likely to reduce the availability of informal caregivers at a 
time when demand is rising. Furthermore, as the population 
ages, informal caregivers may be called upon to care repeat-
edly but their willingness to care more than once declines 
with age.4 These factors may be particularly important 
where changes in policy deliberately, or inadvertently, shift 
costs onto patients and their families. There is, however, 
limited evidence of the economic impact of caring for indi-
viduals receiving palliative and end-of-life care.5
In this edition of Palliative Medicine, two studies illus-
trate nicely the difficulties of obtaining information about 
the costs of informal caregiving. The paper by Bremner 
et al.6 provides important information about costs in the 
last 6 months of life for patients with advanced non-small 
cell lung cancer. This study, using health administrative 
data, provides excellent information from a public payer 
perspective showing that these costs are slightly higher in 
the United States than Canada until the final month. 
However, the findings also highlight a major limitation of 
administrative datasets, as informal care costs could not be 
estimated due to lack of details.
The second paper by Dixon, Matosevic and Knapp7 
presents a systematic review of the economic evidence for 
advance care planning, suggesting that such evidence is 
‘limited and equivocal’ with no published cost-effective-
ness studies identified by the search. Among other issues, 
these authors highlight the lack of any estimation of infor-
mal care costs in any of the 18 papers included in the 
review and call for further research on the quality and eco-
nomic benefits of advance care planning, including gener-
ating cost estimates of the broader impacts on social 
services and informal care.
Two further papers in this issue do, however, provide 
new evidence about informal care costs in different set-
tings. Round, Jones and Morris8 estimate the health, social 
and informal care costs at the end of life for lung, breast, 
colorectal and prostate cancer patients in England and 
Wales; Dumont et al.9 compare public health, patient, fam-
ily and not-for-profit organisational costs occurring during 
6 months participation in a Canadian palliative care pro-
gramme. The findings from these studies suggest that 
between one-fifth and one-third of the overall costs of car-
ing for people at the end of life fall on informal caregivers. 
Round, Jones and Morris modelled the costs of care associ-
ated with the end-of-life period defined as the time between 
initiation of strong opioids and death, whereas Dumont 
et al. investigated costs related to palliative care in patients 
enrolled in a regional palliative care programme near the 
end of life, where approximately 72% of participants died 
during the longitudinal study. Furthermore, informal care 
costs included the value of care provided and lost employ-
ment income in the former study but only time spent pro-
viding care was valued in the latter study. The distinct 
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jurisdictions, healthcare systems, disparity in time period 
and study design may account for the difference in esti-
mates, but nevertheless, it is clear that in both studies, the 
costs of informal caregiving constitute a substantial and 
important component of total cost.
Typically, economic evaluations are conducted from a 
provider or healthcare perspective, thereby excluding 
indirect costs on patients and families. This is for a num-
ber of reasons. Often evaluations are commissioned by 
private health service providers or public providers with 
siloed budgets, and thus there is no imperative or incen-
tive to include indirect costs of this type (in fact, quite the 
opposite!). Internationally, some countries such as 
Australia and the United Kingdom have been slow to 
adopt a societal perspective in guidelines on the conduct 
of economic evaluations for regulatory and reimburse-
ment purposes, impeding consideration of the broader 
impacts of interventions, particularly pertinent in the pal-
liative and end-of-life setting.
The challenges of conducting high-quality research in 
palliative and end-of-life care are well-established. 
Collecting data on informal caregiver outcomes and costs 
places additional demands on research staff and family 
members at a time when informal caregivers may be emo-
tionally and physically compromised and distress is high. 
Furthermore, as Bremner and colleagues illustrated, little 
or no informal caregiver data are routinely collected in 
healthcare administrative databases and acquiring such 
data prospectively requires additional resourcing. Finally, 
there are unresolved philosophical, theoretical and meth-
odological issues such as the appropriate evaluative space 
(utility, health, capability),10 how to allocate the costs of 
joint activities and care specific to palliation, the choice of 
informal caregiver outcome measure and accounting for 
interdependent and potentially conflicting patient and car-
egiver preferences.2
Economic evaluations in the palliative and end-of-life 
care setting are rare and seldom include informal caregiver 
costs and outcomes. We urgently need to understand how 
to maximise the value of palliative and end-of-life care 
services and how best to invest limited resources to 
improve population-wide outcomes, including the resource 
of informal caregiving. While articles published in this 
edition of Palliative Medicine both illustrate the problems 
in the existing literature and start to fill some of the gaps, 
much more research is needed. Continuing to ignore the 
economic burden of informal caregiving is likely to lead to 
cost-shifting and over-burdened family and friends, ulti-
mately threatening the provision of high-quality palliative 
care. We hope that this will be one of the issues that is 
addressed in the forthcoming special issue of Palliative 
Medicine on the Economics of Palliative and End of Life 
Care. Please see our Call for Papers.
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